Persistent acute kidney injury biomarkers: A systematic review and meta-analysis.
Keran ShiWei JiangLin SongXianghui LiChuanqing ZhangLuanluan LiYunfan FengJiayan YangTianwei WangHaoran WangLulu ZhouJiangquan YuRuiqiang ZhengPublished in: Clinica chimica acta; international journal of clinical chemistry (2024)
This meta-analysis discovered CCL14 as the best biomarker to predict persistent AKI, specifically persistent stage 2-3 AKI.